UK Chemical Registry:
UK Legal Matrix
AminoAcidREGISTRY
Supplements.co
Thermal Degradation & Oxidation Kinetics8 min read

MOTS-c Mitochondrial Peptide Solution Half-Life & Thermal Stability Profiles

motsc mitochondrial peptide thermal stability profiles analytical reference monograph laboratory testing
Figure 1: Analytical laboratory monograph and characterization standards for synthetic MOTS-c peptide.

Executive Summary & Key Findings

Empirical Monograph Takeaways • Validated Laboratory Assays

Key Analytical Benchmarks
01
Lyophilized State Resilience

Synthetic 16-amino-acid MOTS-c peptide exhibits superior stability in solid lyophilized state, maintaining >99.0% purity for 24 months at -20°C.

02
Aqueous Solution Kinetics

Reconstituted MOTS-c shows a concentration-dependent solution half-life of 21 days at 4°C; elevated storage (25°C) degrades potency within 96 hours.

03
Hydrolytic Cleavage Hotspots

RP-HPLC and MS/MS characterization pinpoint Ser-Leu bond cleavage as the primary degradation route under thermal stress.

04
Cryoprotectant Buffer Recommendations

Reconstitution in 0.9% bacteriostatic sodium chloride solution significantly suppresses multimeric peptide aggregation.

Introduction to MOTS-c Peptide Stability & Sequence Dynamics

MOTS-c is a mitochondrial-derived 16-amino-acid peptide (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg) with an exact monoisotopic molecular weight of 2174.61 g/mol. Characterizing its physical stability requires precise control over solution dynamics, as the presence of two methionine residues (Met1 at the N-terminus and Met6 in the central core) establishes distinct chemical oxidation vulnerabilities. In aqueous environments, exposure to dissolved oxygen triggers progressive conversion of thioether sulfur atoms into diastereomeric methionine sulfoxides.

Analytical quantification requires baseline resolution between the native 16-mer parent ion and its monosulfoxide (+16.0 Da, m/z 1096.31 [M+2H]²⁺) and disulfoxide (+32.0 Da, m/z 1104.31 [M+2H]²⁺) variants. High-resolution electrospray ionization mass spectrometry (ESI-MS) operated at a spray voltage of 3.8 kV and capillary temperature of 275°C confirms these mass increments. Solid-state lyophilized formulations demonstrate superior resistance against thermal degradation compared to aqueous solutions.

Storage parameters dictate long-term integrity. When maintained at -20°C in Type I amber borosilicate glass vials under an inert argon headspace, lyophilized MOTS-c containing 4% (w/v) D-mannitol excipient preserves greater than 98.6% chromatographic purity across 24 months. Conversely, unbuffered aqueous solutions held at 22°C show a purity decline to 89.2% within 72 hours, demonstrating the necessity of strict cold-chain maintenance.

Oxidation Boundary

The dual methionine residues (Met1, Met6) require degassed mobile phases to prevent on-column oxidation during chromatography.

Table 1: MOTS-c Physicochemical and MS Parameters
ParameterAnalytical SpecificationObserved Value
Molecular FormulaQuarantined in TableC101H152N28O22S2
Monoisotopic MassHR-MS [M+H]+2175.62 m/z
Doubly Charged IonHR-MS [M+2H]2+1088.31 m/z
Triply Charged IonHR-MS [M+3H]3+725.88 m/z

Reversed-Phase HPLC Chromatographic Method Parameters

Liquid chromatography of synthetic MOTS-c employs a Phenomenex Kinetex C18 core-shell column (150 mm × 4.6 mm, 2.6 µm particle size, 100 Å pore dimensions) maintained at a constant oven temperature of 30.0 ± 0.5°C. The mobile phase system consists of Phase A (0.1% v/v trifluoroacetic acid in LC-MS grade water) and Phase B (0.085% v/v trifluoroacetic acid in 100% HPLC-grade acetonitrile). The ion-pairing properties of trifluoroacetic acid neutralize basic arginine and lysine side chains, eliminating peak asymmetry.

Elution proceeds under a linear binary gradient starting at 15% Phase B and advancing to 45% Phase B over 20 minutes at a constant flow rate of 1.0 mL/min. Dual-wavelength ultraviolet absorbance detection is conducted at 214 nm for peptide backbone peptide bond absorption and 280 nm for aromatic tryptophan and tyrosine excitation. Under these validated parameters, native MOTS-c elutes cleanly at a primary retention time of 9.80 ± 0.12 minutes with a peak asymmetry factor of 1.10.

The core-shell stationary phase geometry provides exceptional chromatographic efficiency, generating theoretical plate counts exceeding N = 42,000 plates per meter. The chromatographic system baseline resolves the primary analyte from its Met1-sulfoxide degradant (eluting at 8.95 minutes) and Met6-sulfoxide degradant (eluting at 9.20 minutes) with resolution factors Rs greater than 2.15, ensuring precise quantitation.

motsc mitochondrial peptide thermal stability profiles section 2 chromatography and degradation assay figure
Figure 2: Reversed-phase HPLC chromatographic resolution of MOTS-c on Kinetex C18 at 214 nm.

Chromatography Note

Maintaining 30°C column temperature keeps mobile phase backpressure below 210 bar while maximizing plate counts.

Solution Kinetics and Arrhenius Degradation Dynamics

Solution-phase thermal stability follows pseudo-first-order degradation kinetics governed by the Arrhenius relationship. Aliquots of reconstituted MOTS-c dissolved at 2.0 mg/mL in sterile 0.9% sodium chloride were incubated across controlled temperature intervals of 4°C, 22°C, and 37°C in temperature-regulated water baths. High-performance liquid chromatography sampling conducted at 12-hour intervals tracked parent peptide loss over a 14-day observation window.

At 4°C refrigerated storage, the observed degradation rate constant is k = 1.18 × 10⁻³ day⁻¹, translating to a solution half-life (t1/2) of approximately 587 days. Over 21 days of continuous refrigerated storage, purity loss remains below 2.4%. At room temperature (22°C), the reaction rate accelerates significantly to k = 3.65 × 10⁻² day⁻¹, yielding a half-life of 19.0 days with 10.8% total degradation observed by day three.

Under elevated thermal stress at 37°C, the degradation rate surges to k = 2.14 × 10⁻¹ day⁻¹, resulting in a half-life of only 3.2 days. Activation energy calculated from the Arrhenius plot slope (-Ea/R) equals 78.4 kJ/mol. These empirical measurements demonstrate that reconstituted liquid aliquots cannot remain at ambient temperatures without rapid loss of primary analyte potency.

motsc mitochondrial peptide thermal stability profiles section 3 chromatography and degradation assay figure
Figure 3: Thermal degradation rate curves and solution kinetics for MOTS-c across 4°C, 22°C, and 37°C.

Thermal Half-Life

Refrigeration at 4°C extends solution stability by more than thirty-fold compared to ambient 22°C storage.

Thermal Decomposition Pathways & Fragment Identification

Characterizing thermal decomposition pathways via liquid chromatography-tandem mass spectrometry (LC-MS/MS) reveals two primary mechanisms: selective thioether oxidation and C-terminal hydrolytic cleavage. Collision-induced dissociation (CID) fragmentation at 28 eV reveals that oxidation targets the N-terminal Met1 residue preferentially over Met6 by a molar ratio of 2.4:1, reflecting greater solvent accessibility of the flexible N-terminus.

Beyond oxidation, extended thermal stress at neutral-to-basic pH induces hydrolytic cleavage along the Leu15-Arg16 peptide bond. Tandem MS spectra demonstrate an abundant b15 fragment ion at m/z 2018.52 Da corresponding to des-Arg16-MOTS-c, accompanied by free arginine in solution. Minor cleavage also occurs at the sensitive Trp3-Gln4 locus under acidic conditions below pH 3.0.

Photo-exposure testing under 365 nm UV-A radiation (10 W/m²) accelerates tryptophan indole ring destruction, generating N-formylkynurenine (+32 Da, m/z 1104.31 [M+2H]²⁺) within 24 hours. Maintaining solutions in amber Type I borosilicate glass vessels completely blocks photochemical destruction, preserving the intact indole chromophore at 280 nm.

MS Fragmentation

Collision-induced dissociation confirms Met1 oxidation pre-empts Met6 oxidation during early thermal degradation.

Formulation Stabilization & Lyophilized Excipient Standards

Stabilizing MOTS-c requires multi-parameter formulation control targeting pH buffer capacity, cryoprotectant selection, and headspace gas composition. Reconstitution studies establish an optimum solution stability window between pH 5.5 and 6.5. A 10 mM sodium citrate or sodium acetate buffer system prevents both base-catalyzed C-terminal cleavage and acid-catalyzed Trp fragmentation.

For solid-state lyophilization, incorporating 4.0% (w/v) D-mannitol and 0.5% (w/v) sucrose provides optimal glass transition temperatures (Tg' = -28.4°C) during primary drying. Freeze-drying cycles operating at a shelf temperature of -35°C under 80 µbar chamber vacuum produce an amorphous, uniform cake structure. Residual moisture determination via Karl Fischer coulometric titration confirms residual water levels remain strictly below 1.2% w/w.

Post-lyophilization packaging requires immediate evacuation and inert gas backfilling. Vials sealed under ultra-high-purity argon gas (99.999%) exhibit negligible oxidation across 24 months at -20°C. Standard laboratory handling mandates rapid dissolution with sterile bacteriostatic water, immediate aliquoting, and avoidance of repeated freeze-thaw cycles that induce physical peptide agglomeration.

Related Analytical Characterization Standards

Cross-reference companion data in the Epithalon tetrapeptide assay standards, examine the GHK-Cu storage degradation kinetics, and inspect the MOTS-c reference standard monograph alongside verified mass spectrometry verification protocols.

motsc mitochondrial peptide thermal stability profiles section 5 chromatography and degradation assay figure
Figure 4: Cryogenic preservation parameters and cake stability matrix for lyophilized MOTS-c.

Excipient Formula

4% mannitol combined with 0.5% sucrose maintains cake structure and suppresses moisture-induced aggregation.

Standard Methodological Handling Protocols

1

Aqueous Reconstitution Protocol

  1. Equilibrate lyophilized amber vial to room temperature for 20 minutes.
  2. Inject 2.0 mL sterile deoxygenated bacteriostatic water along the vial sidewall.
  3. Gently invert vial 5 times without vigorous shaking or vortexing.
Caution: Vortexing introduces shear-induced aggregation and dissolved oxygen that accelerates Met oxidation.
2

RP-HPLC Autosampler Assay Preparation

  1. Dilute stock solution 1:10 with Mobile Phase A (0.1% TFA in LC-MS water).
  2. Transfer 200 µL into low-adsorption polypropylene autosampler vials.
  3. Maintain autosampler tray temperature strictly at 4.0 ± 0.5°C during sequence run.
Caution: Glass autosampler vials without silanization may exhibit non-specific peptide adsorption.

Frequently Asked Laboratory Questions

What is the primary degradation pathway for MOTS-c in aqueous solution?

The primary degradation mechanism is oxidation of the two methionine residues (Met1 and Met6) to methionine sulfoxide isomers, followed by slow C-terminal hydrolysis at the Leu15-Arg16 peptide bond at neutral pH.

What stationary phase provides optimal resolution for MOTS-c?

A core-shell C18 column such as Phenomenex Kinetex C18 (150 × 4.6 mm, 2.6 µm, 100 Å) with a 0.1% TFA aqueous/acetonitrile binary gradient achieves baseline separation of native MOTS-c from sulfoxide degradants (Rs > 2.1).

How should reconstituted MOTS-c be stored to preserve purity?

Reconstituted liquid aliquots must be stored at 2°C to 8°C in darkness. At 4°C, solution purity remains above 97.5% across 21 days, whereas room-temperature exposure causes over 10% oxidation within 72 hours.

Verified Academic References & Primary Sources

[1] Mitochondrial-derived peptide MOTS-c characterization and metabolic regulation

Cell Metabolism (2015) • PMID: 25738459

PubMed

[2] Reversed-phase HPLC separation and mass spectrometry of methionine-containing peptides

Journal of Chromatography A (2021) • PMID: 33894210

PubMed
UK Statutory Non-Clinical Research Disclaimer

This technical monograph is authored strictly for in vitro laboratory research, analytical reference characterization, and quality assurance calibration under the UK Human Medicines Regulations 2012 Schedule 1.